Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02725541
Title Trial of Neoadjuvant Trastuzumab Emtansine in Patients With HER2-Equivocal Breast Cancer
Recruitment Withdrawn
Gender female
Phase Phase II
Variant Requirements No
Sponsors The Methodist Hospital System
Age Groups: adult
Covered Countries USA

No variant requirements are available.